Edward White
Stock Analyst at HC Wainwright & Co.
(1.85)
# 3,252
Out of 5,112 analysts
362
Total ratings
30.89%
Success rate
-8.21%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $9.59 | +244.11% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $8.24 | +106.31% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.80 | +212.50% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.96 | +51.52% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.17 | +1,267.52% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.59 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $8.44 | +847.87% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $0.85 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $4.32 | +362.96% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.45 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.46 | +362.43% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.86 | +326.62% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.01 | +692.08% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $19.25 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.47 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $31.13 | +76.68% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $20.37 | +150.37% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.58 | +25.45% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $6.02 | +830.23% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.79 | +187.30% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.21 | +409.30% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.82 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $29.06 | +2,308.81% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $33.73 | -11.06% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.05 | +1,042.86% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $9.59
Upside: +244.11%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $8.24
Upside: +106.31%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.80
Upside: +212.50%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.96
Upside: +51.52%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.17
Upside: +1,267.52%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $8.44
Upside: +847.87%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.85
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $4.32
Upside: +362.96%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.45
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.46
Upside: +362.43%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.86
Upside: +326.62%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.01
Upside: +692.08%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $19.25
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.47
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $31.13
Upside: +76.68%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $20.37
Upside: +150.37%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $5.58
Upside: +25.45%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $6.02
Upside: +830.23%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.79
Upside: +187.30%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.21
Upside: +409.30%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.82
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $29.06
Upside: +2,308.81%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $33.73
Upside: -11.06%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.05
Upside: +1,042.86%